In this Feb. 27, 2020, file photo, the DoorDash app is shown on a smartphone in New York. (AP Photo, File)
One of the largest delivery platforms in the U.S., DoorDash is getting into the growing prescription drug delivery business through a partnership with wholesale giant Sam's Club.
“Our partnership with DoorDash to launch this new service allows us to not only give our members more convenient healthcare options, but also delivers on our commitment to their overall wellness needs,” said John McDowell, vice president of pharmacy operations and divisional merchandise at Sam’s Club, in a statement.
DoorDash is tapping Drive, its white-label fulfillment platform for merchants, to power the partnership, which emerged specifically to meet shifting consumer expectations amid COVID.
“Businesses have evolved amidst the pandemic to prioritize the safety of their communities and to adapt to new consumer habits, and our goal is to help merchants meet those demands in a way that’s best for their business,” said Christopher Payne, chief operating officer at DoorDash.
The coronavirus pandemic has accelerated the adoption of prescription drug delivery services. Pharmacies in particular have turned to third parties to compete with online retailers.
For DoorDash, the partnership comes as the platform teams up with other companies outside of the food category, including PetSmart, Macy's, Walgreens, CVS Pharmacy, and 7-Eleven.
DoorDash will provide same-day delivery across Sam Club's 500 locations.
Sam's Club is offering free delivery on their first two pharmacy orders until the end of the year and then charging a flat fee of $7.99 per order.
Former Medtronic CEO and author of 'True North' Bill George explains the steps Boeing leadership must take to regain client and consumer trust after 737 Max 9 production was stopped.
Amazon blamed "regulatory hurdles" for calling off its proposed acquisition of robot vacuum maker iRobot. Not even a Roomba could clean up the deal's antitrust scrutiny.
To celebrate Flutter Entertainment's debut on the NYSE, FanDuel CEO Amy Howe shares her thoughts on the company's plans for growth, the future of online sportsbetting, and Super Bowl Sunday.
Investopedia's Caleb Silver shares thoughts on the upcoming Fed meeting, why individual investors are still slightly skeptical, and what he's looking for from mega cap tech earnings.
Season's greetings! Tax season, that is. January 29 is the first day you can file your tax return. We walk you through each step — plus a checklist you can download.
The Q-Collar helps protect athletes from impact-related concussions. Now, the U.S. Army is evaluating if the device could help reduce traumatic brain injury cased by blast weapons.
Co-founder and executive chairman of the board at Vaxxinity Lou Reese shares how the company is working to bring vaccines for chronic illnesses like heart disease and Parkinson’s to market with an eye for accessibility.
Mario Veneroso, Kingsview Asset Management Partner, weighs in on the latest economic data and whether the market is pricing in too many rate cuts for the coming year.
